Category Archives: Cardiovascular

Importance  Mendelian randomization (MR) is a statistical approach that has become increasingly popular in the field of cardiovascular disease research. It offers a way to infer potentially causal relationships between risk factors and outcomes using observational data, which is particularly important in cases where randomized clinical trials are not feasible or ethical. With the growing […]

Abstract Background The association between obesity and cardiovascular disease (CVD) in people without traditional CVD risk factors is unclear. This study aimed to investigate the association of obesity with CVD and its subtypes in people without traditional CVD risk factors. Methods Based on the Kailuan cohort study, the included participants were divided into different groups […]

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of Cardiovascular Diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010 Article  PubMed Central  PubMed  Google Scholar  Shengshou H. Report on cardiovascular health and Diseases burden in China: an updated summary […]

Awarded biennially, the Schottenstein Prize honors those at the forefront of cardiovascular sciences. Recipients of the prize have made extraordinary and sustained leadership contributions to improving health care. The Schottenstein Prize is among the largest monetary prizes in the United States dedicated to cardiovascular research. Kitsis will receive an honorarium of $100,000 and be honored […]

Two studies presented Monday at the American Heart Association Scientific Sessions in Philadelphia identify a correlation between marijuana use and heart issues, per CNN. The first study, which focused on adults age 65 or older with cannabis use disorder, determined that abusing marijuana is a risk factor for a number of cardiovascular conditions. “Researchers found […]

Micrograph of a heart with fibrosis (yellow) and amyloidosis (brown). Movat’s stain. Credit: Nephron/Wikipedia New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPLs) are autoantibodies […]

<div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2023/changes-in-cardiovascu.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2023/changes-in-cardiovascu.jpg" data-sub-html="Estimates of Annual Cardiovascular Disease (CVD) Incidence, Prevalence, Mortality, and Disability-Adjusted Life-Year (DALY) Rates per 100,000 in China before and after the Introduction of the 2011 CSC Guidelines, by Sex (Left Panel) and Age Group (Right Panel), with the Composite Synthetic Controls. Dots represent the observed CVD burden from 1990 to 2019. […]

COPENHAGEN, Nov 7 (Reuters) – Danish drugmaker Novo Nordisk (NOVOb.CO) said on Tuesday it will present new cardiometabolic disease data, including results from its SELECT trial, at the annual American Heart Association Scientific Sessions from Nov. 11-13. Novo’s SELECT trial earlier this year concluded that the highly effective Wegovy obesity treatment also had a clear […]

The increasing prevalence of cardiometabolic health conditions, such as obesity, type 2 diabetes, cardiovascular disease, and chronic kidney disease, since the turn of the century has placed a significant strain on health systems and, as a result, has led to significant reform in the management of these diseases. Beginning in the early 2000s, clinicians and […]